Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
批准号:
10826448
负责人:
Agnel Sfeir
金额:
$54.29万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2028-05-31
关键词:
AgingBase PairingBiogenesisBrainCell AgingCell physiologyCellsChronic progressive external ophthalmoplegiaDNA RepairDiseaseDrosophila genusEpithelial CellsFibroblastsFunctional disorderGeneticGenomeGenome StabilityGenomic InstabilityInterphase CellKearns-Sayre syndromeLinkMammalian CellMethodologyMethodsMitochondriaMitochondrial DNAMitosisMonitorMuscleMuscle CellsMutateNeuronsNuclearOutputOxidative PhosphorylationPathologyPathway interactionsPhysiologicalPositioning AttributeProcessSeriesSomatic CellSpecificityTestingTissuesage relatedbiological adaptation to stresscell typedimerembryonic stem cellexperiencegenome integrityheteroplasmyinsightmitochondrial DNA mutationmitochondrial dysfunctionmitochondrial genomemodel organismmutantnovelparticlepostmitoticpreventreconstitutionrepairedrespiratoryresponsetooltranscription activator-like effector nucleasestranscriptomics
中文摘要
项目摘要:
最常见的线粒体DNA(mtDNA)异常是4977个碱基对的缺失
称为共同缺失(CD),与线粒体病理学相关,广泛分布于
衰老当删除的分子超过时,CD主要表现在大脑和肌肉中
占总拷贝数的60%,称为异质性。然而,造成有害的机制
缺失以及为什么神经元和肌肉细胞特别容易受到CD的影响仍然不清楚。
研究CD的主要障碍是缺乏操纵mtDNA的工具,
以受控的方式生成CD。在这里,我们开发了一系列方法,
克服这些障碍。具体来说,我们产生了一种诱导型准二聚体TALEN,
在同基因设置和定义的异质性状态下产生CD。有了这个工具,我们将
在胚胎干细胞中建立低、中、高水平的CD异质性,
然后分化成肌肉、神经元和成纤维细胞,并阐明
这种有害的缺失以细胞类型特异性的方式及其对细胞衰老的影响。此外,委员会认为,
我们将探索CD的细胞类型特异性分布,确定维持CD的途径,
突变mtDNA在有丝分裂后细胞中增殖,同时促进其在分裂细胞中的消除。
将新的遗传工具与基因组稳定性方面的丰富经验相结合,
有丝分裂后细胞中优先突变mtDNA繁殖的长期谜团,
对许多线粒体病理学和衰老有重要意义。
英文摘要
Project Summary:
The most common mitochondrial DNA (mtDNA) abnormality is a deletion of 4977 base pairs
called the common deletion (CD), associated with mitochondrial pathologies and widespread in
aging. The CD primarily manifests in the brain and muscles when deleted molecules exceed
60% of total copies, known as heteroplasmy. However, the mechanisms that cause harmful
deletions and why neuronal and muscle cells are particularly vulnerable to CD remain unclear.
Major obstacles to studying the CD is the lack of tools to manipulate mtDNA and the inability to
generate the CD in a controlled manner. Here, we developed a series of methodologies to
overcome these barriers. Specifically, we generated an inducible quasi-dimeric TALEN that
generates the CD in isogenic settings and at defined heteroplasmy states. With this tool, we will
establish low, medium, and high levels of CD heteroplasmy in embryonic stem cells that we will
then differentiate into muscle, neuronal, and fibroblast cells and elucidate the consequence of
this harmful deletion in a cell-type-specific manner and its impact on cellular aging. Furthermore,
we will explore the cell-type-specific distribution of CD, Identifying the pathways that sustain
mutant mtDNA propagation in post-mitotic cells while promoting its elimination in dividing cells.
Combining novel genetic tools with extensive experience in genome stability will resolve the
long-standing mystery of preferential mutant mtDNA propagation in post-mitotic cells and have
significant implications for numerous mitochondrial pathologies and aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Define the Role of POT1 Mutation in Genome Instability and Cancer
-
批准号:10221642
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10379672
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Define the Role of POT1 Mutation in Genome Instability and Cancer
-
批准号:10379657
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10576792
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10320939
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10090458
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2019
-
负责人:Agnel Sfeir
-
依托单位:
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac
-
批准号:9298637
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:Agnel Sfeir
-
依托单位:
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac
-
批准号:8749789
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:Agnel Sfeir
-
依托单位:
海外基金